171 related articles for article (PubMed ID: 11427527)
1. A novel approach to the design of inhibitors of human secreted phospholipase A2 based on native peptide inhibition.
Church WB; Inglis AS; Tseng A; Duell R; Lei PW; Bryant KJ; Scott KF
J Biol Chem; 2001 Aug; 276(35):33156-64. PubMed ID: 11427527
[TBL] [Abstract][Full Text] [Related]
2. Native peptide inhibition. Specific inhibition of type II phospholipases A2 by synthetic peptides derived from the primary sequence.
Tseng A; Inglis AS; Scott KF
J Biol Chem; 1996 Sep; 271(39):23992-8. PubMed ID: 8798633
[TBL] [Abstract][Full Text] [Related]
3. Purified group X secretory phospholipase A(2) induced prominent release of arachidonic acid from human myeloid leukemia cells.
Hanasaki K; Ono T; Saiga A; Morioka Y; Ikeda M; Kawamoto K; Higashino K; Nakano K; Yamada K; Ishizaki J; Arita H
J Biol Chem; 1999 Nov; 274(48):34203-11. PubMed ID: 10567392
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic action of secreted phospholipase A2 in prostate cancer.
Sved P; Scott KF; McLeod D; King NJ; Singh J; Tsatralis T; Nikolov B; Boulas J; Nallan L; Gelb MH; Sajinovic M; Graham GG; Russell PJ; Dong Q
Cancer Res; 2004 Oct; 64(19):6934-40. PubMed ID: 15466184
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study.
Smart BP; Pan YH; Weeks AK; Bollinger JG; Bahnson BJ; Gelb MH
Bioorg Med Chem; 2004 Apr; 12(7):1737-49. PubMed ID: 15028265
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.
Fujita M; Zhu K; Fujita CK; Zhao M; Lam KS; Kurth MJ; Takada YK; Takada Y
J Biol Chem; 2015 Jan; 290(1):259-71. PubMed ID: 25398877
[TBL] [Abstract][Full Text] [Related]
7. A bifunctional role for group IIA secreted phospholipase A2 in human rheumatoid fibroblast-like synoviocyte arachidonic acid metabolism.
Bryant KJ; Bidgood MJ; Lei PW; Taberner M; Salom C; Kumar V; Lee L; Church WB; Courtenay B; Smart BP; Gelb MH; Cahill MA; Graham GG; McNeil HP; Scott KF
J Biol Chem; 2011 Jan; 286(4):2492-503. PubMed ID: 21068383
[TBL] [Abstract][Full Text] [Related]
8. Secreted phospholipase A2 inhibitors are also potent blockers of binding to the M-type receptor.
Boilard E; Rouault M; Surrel F; Le Calvez C; Bezzine S; Singer A; Gelb MH; Lambeau G
Biochemistry; 2006 Nov; 45(44):13203-18. PubMed ID: 17073442
[TBL] [Abstract][Full Text] [Related]
9. Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s.
Suzuki N; Ishizaki J; Yokota Y; Higashino K; Ono T; Ikeda M; Fujii N; Kawamoto K; Hanasaki K
J Biol Chem; 2000 Feb; 275(8):5785-93. PubMed ID: 10681567
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of novel mouse and human secretory phospholipase A(2)s.
Ishizaki J; Suzuki N; Higashino K; Yokota Y; Ono T; Kawamoto K; Fujii N; Arita H; Hanasaki K
J Biol Chem; 1999 Aug; 274(35):24973-9. PubMed ID: 10455175
[TBL] [Abstract][Full Text] [Related]
11. Design of specific peptide inhibitors of phospholipase A2: structure of a complex formed between Russell's viper phospholipase A2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS).
Chandra V; Jasti J; Kaur P; Dey S; Srinivasan A; Betzel Ch; Singh TP
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1813-9. PubMed ID: 12351825
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.
Oslund RC; Gelb MH
Biochemistry; 2012 Oct; 51(43):8617-26. PubMed ID: 23020658
[TBL] [Abstract][Full Text] [Related]
13. A novel role of group VIB calcium-independent phospholipase A2 (iPLA2gamma) in the inducible expression of group IIA secretory PLA2 in rat fibroblastic cells.
Kuwata H; Fujimoto C; Yoda E; Shimbara S; Nakatani Y; Hara S; Murakami M; Kudo I
J Biol Chem; 2007 Jul; 282(28):20124-32. PubMed ID: 17475622
[TBL] [Abstract][Full Text] [Related]
14. Identification of a specific region of low molecular weight phospholipases A2 (residues 21-40) as a potential target for structure-based design of inhibitors of these enzymes.
Cordella-Miele E; Miele L; Mukherjee AB
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10290-4. PubMed ID: 7694288
[TBL] [Abstract][Full Text] [Related]
15. Crystallization and preliminary X-ray diffraction studies of a new crystal form of human secretory type IIA phospholipase A2.
Church WB; Lei PW; Ogg DJ; Scott KF
Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1482-4. PubMed ID: 11053860
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of a complex formed between a snake venom phospholipase A(2) and a potent peptide inhibitor Phe-Leu-Ser-Tyr-Lys at 1.8 A resolution.
Chandra V; Jasti J; Kaur P; Dey S; Perbandt M; Srinivasan A; Betzel Ch; Singh TP
J Biol Chem; 2002 Oct; 277(43):41079-85. PubMed ID: 12186870
[TBL] [Abstract][Full Text] [Related]
17. Interfacial enzymology of parvovirus phospholipases A2.
Canaan S; Zádori Z; Ghomashchi F; Bollinger J; Sadilek M; Moreau ME; Tijssen P; Gelb MH
J Biol Chem; 2004 Apr; 279(15):14502-8. PubMed ID: 14726513
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors.
Antonio V; Brouillet A; Janvier B; Monne C; Bereziat G; Andreani M; Raymondjean M
Biochem J; 2002 Dec; 368(Pt 2):415-24. PubMed ID: 12188923
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2.
Pruzanski W; Lambeau G; Lazdunski M; Cho W; Kopilov J; Kuksis A
Biochim Biophys Acta; 2007 Jan; 1771(1):5-19. PubMed ID: 17197234
[TBL] [Abstract][Full Text] [Related]
20. Anthrax lethal toxin down-regulates type-IIA secreted phospholipase A(2) expression through MAPK/NF-kappaB inactivation.
Raymond B; Ravaux L; Mémet S; Wu Y; Sturny-Leclère A; Leduc D; Denoyelle C; Goossens PL; Payá M; Raymondjean M; Touqui L
Biochem Pharmacol; 2010 Apr; 79(8):1149-55. PubMed ID: 19962969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
